{"id":3082,"date":"2018-07-12T10:53:53","date_gmt":"2018-07-12T08:53:53","guid":{"rendered":"https:\/\/specialistcannabinoids.umh.es\/?page_id=3082"},"modified":"2024-07-18T13:31:19","modified_gmt":"2024-07-18T11:31:19","slug":"scheme","status":"publish","type":"page","link":"https:\/\/specialistcannabinoids.umh.es\/es\/scheme\/","title":{"rendered":"COURSE"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; disabled_on=\u00bboff|off|off\u00bb admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.16&#8243; global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.17.4&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.17.4&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_color=\u00bb#ffffff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><strong>0. Introduction<\/strong><br \/><strong><\/strong><\/p>\n<p><strong><span style=\"color: #0000ff\">Cannabis: therapeutic or recreational drug<\/span><\/strong><\/p>\n<p><strong><span style=\"color: #0000ff\">\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1UQOwp5aYne9TGExi06IZFovd2Nx0SH4S\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n <\/span><\/strong><strong><\/strong><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><strong>Section 1. Botany, pharmacognosy, pharmacology and recreational use of the cannabis plant<\/strong><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.1. History of cannabis, from its origins to today&#8217;s products<\/strong><\/span><\/p>\n<p>Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1_wrRzb3lx1geBgax_kvuLJ87nMJkmqPK\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n <\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.2. Taxonomy and botany of cannabis. Macroscopic and microscopic characteristics<\/strong><\/span><\/p>\n<p>Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1FqpRbin6XU9dSjFS-8POb_v8NgrD5Zy2\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n <\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.3. Phytochemistry of cannabis: main families of compounds and their main pharmacological uses<\/strong><\/span><\/p>\n<p>Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1lgYPEupapDwQXFVkGn_0kPtw5H1iZnF7\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.4. Main analytical techniques for the characterization of cannabis compounds. Good Laboratory Practices (GLP)<\/strong><\/span><\/p>\n<p>Prof. Enrique Barraj\u00f3n Catal\u00e1n, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1ffFMbZUuC0XoXgcMIf1AdIPxlaHDKqFS\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n <\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.5. Techniques for the extraction of active compounds from cannabis<\/strong><\/span><\/p>\n<p>Prof. Enrique Barraj\u00f3n Catal\u00e1n, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/17Is5UQElCoWQm9CDofpRDyZEXgHoYMzx\/preview\" width=\"640\" height=\"480\" 0=\"allow\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.6. Pharmacology of cannabinoids (endogenous ligands, receptors, synthesis and degradation enzymes)<\/strong><\/span><\/p>\n<p>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1vOkfSnhb1aqL1UKdBkuhwJh8IyLoMXGo\/preview\" width=\"640\" height=\"480\" 0=\"allow\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 1.7. Cannabinoid signaling in the brain: extracting specificity from ubiquity<\/strong><\/span><\/p>\n<p>Prof. Giovanni Marsicano, NeuroCentre Magendie INSERM, University of Bordeaux, France<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/13ykeTD9vHQYduFIpkX_o0sZLrsJ7YQQX\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=\u00bbon|on|off\u00bb admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #333333\"><strong>Section 2. Alterations of the cannabinoid system in animal experimentation and clinical pathology<\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.1. Endocannabinoid system components as potential biomarkers\u00a0<\/strong><\/span><\/p>\n<p>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1XLWEi0hts_6N5wY9CIxbeaRp1oL2TFkD\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=\u00bbon|on|off\u00bb admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.2. Immunohistochemistry, conventional and confocal microscopy, western blots\u00a0<\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1s1YQKIykG0rZZiN_rkhTm12nM9qA8zvb\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][et_pb_divider show_divider=\u00bboff\u00bb disabled_on=\u00bbon|on|off\u00bb admin_label=\u00bbSeparador\u00bb _builder_version=\u00bb4.16&#8243; hide_on_mobile=\u00bbon\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]\u00a0[\/et_pb_divider][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.3. Methodology for detecting changes in ECS components: gene expression, polymorphisms and epigenetics<\/strong><\/span><\/p>\n<p>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1L4SwPIaiW9sS3oXgYwA-dRfO2DnNsddk\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=\u00bbon|on|off\u00bb admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.4. Methodology for detecting changes in ECS components: biochemistry<\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong> <\/strong><\/span>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1bVlPs52ZV0ibR8eMwcrMdMlizuElvu7g\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.5. Methods for detecting changes in the ECS components: neuroimaging<\/strong><\/span><\/p>\n<p>Prof. Silvia de Santis, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1B9IP3TfIn3ExLJ4xl7fOrJg6DL28wB8V\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.6. Alterations of the endocannabinoid system in gastrointestinal diseases<\/strong><\/span><\/p>\n<p>Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1L1ttRiiFJg7e4wG6cuXTjgz3jK-puNWu\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.7. Alterations of the endocannabinoid system in liver diseases<\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/12Jy_rbXk3hm82f-SJdPNPEFV3OXgHrmh\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.8. Alterations of the endocannabinoid system in renal diseases<\/strong><\/span><\/p>\n<p>Prof. Mar\u00eda Salud Garc\u00eda Guti\u00e9rrez, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/180dqHXQuPfjabkHh_CCh0sBFLLk6gF9K\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p><span><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.9. Alterations of the endocannabinoid system in endrocrinology<\/strong><\/span><\/p>\n<p>Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1mGl_yly6-R8UIr04FWojdMD7x_f_0ycb\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p><span><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.10. Alterations of the endocannabinoid system in respiratory diseases<\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1H0STZxdEPefKZNdC3Q7Uv_pZ10h6P8ns\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.11. Alterations of the endocannabinoid system in oncology<\/strong><\/span><\/p>\n<p>Prof. Ana Luc\u00eda Yuste, Department of Oncology, Hospital General de Alicante, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1Ia2nh0I779h7s660Ov7DjeLJO7_6QMTl\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p><span><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.12. Changes in the endocannabinoid system in pain and inflammation<\/strong><\/span><\/p>\n<p>Prof. Katarzyna Starowicz, Maj Institute of Pharmacology Polish Academy of Sciences, Poland<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1OnUuSj_iL05GCVsYlAx-HZKwp28-iaGo\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p><span><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.13. Alterations of the endocannabinoid system in neurology<\/strong><\/span><\/p>\n<p>Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1m9BdiOrLyh1cJy-SnHC-WNjQIlTM5_ST\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1pFeYbpKqbS-Yspj0o5mkxDieg-rMHutM\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 2.14. Alterations of the endocannabinoid system in psychiatry<\/strong><\/span><\/p>\n<p>Prof. Mar\u00eda Salud Garc\u00eda Guti\u00e9rrez, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p><span>\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1d-ejL5MzT2c_W1vO1n5ugGbUHHgqM3bw\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n<\/span><\/p>\n<p><span><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=\u00bbon|on|off\u00bb admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #333333\"><strong>Section 3. Therapeutic uses of cannabinoid derivatives I (pain, neurology and psychiatry)<\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.1. Therapheutic applications of cannabinoids in pain management\u00a0<\/strong><\/span><\/p>\n<p>Prof. Raquel Salda\u00f1a, Anaesthesia Section at Hospital 12 De Octubre, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1Eu9aN4cyBow2PTqDqZLx5m22MNyWWZuA\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><strong style=\"color: #0000ff\">Lecture 3.2. Therapheutic applications of cannabinoids <strong>in the management of neuropathic pain\u00a0<\/strong><\/strong><\/p>\n<p>Prof. Katarzyna Starowicz. Maj Institute of Pharmacology Polish Academy of Sciences, Poland<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1uQ0eMO_UHfg0zdxYJY9zyiRSkHGWWy7n\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.3. Cannabinoid therapy in epilepsy and epileptic syndromes <\/strong><\/span><\/p>\n<p>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1F6YgroydyZZgtQjD9VbNFNDy7ETSJWxr\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.4. Multiple sclerosis: role of cannabinoids in treatment and pathophysiological aspects<\/strong><\/span><\/p>\n<p>Prof. Mar\u00eda Salud Garc\u00eda Guti\u00e9rrez, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1Qox2E60ff7Phk_yMI0UgFAYIjm37c9XM\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.5. Cannabinoids and extrapyramidal pathology: Parkinson&#8217;s disease and other extrapyramidal diseases (dystonia, Gilles Tourette syndrome, tics, etc.)\u00a0<\/strong><\/span><\/p>\n<p>Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1f-y5WoLCdzMX0TAkGM5bepn6AJAgGfCd\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1lLQCJxsvKeTeckSm8czSJMBJbYqs5o_V\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.6. Role of cannabinoids in migraine <\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1iDgRYKAyMFd6Fcm0HDACX1CpOiwULfrN\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.7. Therapeutic usefulness of cannabinoids in anxiety and depressive disorders <\/strong><\/span><\/p>\n<p>Prof. Mar\u00eda Salud Garc\u00eda Guti\u00e9rrez, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1waS5pSCJmqdLpO-xbmsYN6aGpP415Tke\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.8. Role of cannabinoid CB2 receptor in the regulation of emotional and addictive behaviors<\/strong><\/span><\/p>\n<p>Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/11-mhsMKMMmdcqIPSmR_snw_3-jR6Lsmr\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.9. Role of cannabidiol and sertraline in regulating behavioral and brain gene expression changes in a novel animal model of posttraumatic stress disorder<\/strong><\/span><\/p>\n<p>Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1C822-gp72vG9rVGpJKr44ygoaZ6Y_LPq\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 3.10. Role of cannabidiol in drug dependence<\/strong><\/span><\/p>\n<p>Prof. Jorge Manzanares Robles, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/12av9IxDJX-pBcE4R1x3XBeDqtI6cDUVV\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #333333\"><strong>Section 4. Therapeutic uses of cannabinoid derivatives II <\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.1. Regulation of the immune system by cannabinoids: inflammation and infection<\/strong><\/span><\/p>\n<p>Prof. Esther Caparr\u00f3s Cayuela, Department Clinical Medicine, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1HnfALmsUT7wIvJsfAIfbrPacNYQf2Q8a\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.2. Effect of cannabinoids in different immune system pathologies<\/strong><\/span><\/p>\n<p>Prof. Esther Caparr\u00f3s Cayuela, Department Clinical Medicine, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1u51j8hmMCRMd9hVdaK3TZzPJpQecqleh\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.3. Cannabinoid system-intestinal microbiome relationship: physiology and pathology<\/strong><\/span><\/p>\n<p>Prof. Esther Caparr\u00f3s Cayuela, Department Clinical Medicine, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1N-u3q-exInp2g8UDm_EgrpRmkWEKR14P\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.4. Utility of cannabinoid therapy in cardiovascular pathology<\/strong><\/span><\/p>\n<p>Prof. Mar\u00eda Salud Garc\u00eda Guti\u00e9rrez, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1EzhB9T1oy6auSmo2qfaK-o_s8x6chy-F\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.5.Role of the endocannabinoid system in energy balance and obesity<\/strong><\/span><\/p>\n<p>Prof. Daniela Cota, NeuroCentre Magendie INSERM, University of Bordeaux, France<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1lNjfa9ggmqu0wa2hResZXJtErPh2p9qi\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.6. Therapeutic potential of the use of cannabinoid compounds in the treatment of renal pathologies<\/strong><\/span><\/p>\n<p>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1OQVGJDRez4ZuF55fgwG6jpET0e8_2bhG\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.7. Potential therapeutic utility of cannabinoid compounds in liver diseases\u00a0<\/strong><\/span><\/p>\n<p>Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1ZItf_MwoiW_x1BmpHiZvDXUX4X14rrp7\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.8. Potential therapeutic utility of cannabinoid compounds in respiratory pathologies <\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.9. Usefulness of the use of cannabinoids in traumatology<\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1UsTfnJsNH8ZbFQu8v88dbaJ9pwx7w-Jm\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.10. Effects of cannabinoids on bone tissue<\/strong><\/span><\/p>\n<p>Prof. Daniela Navarro, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1glAmmfFIVcCSOdLn5gaKGz1aOBAQ3peO\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.11. Potential therapeutic utility of cannabinoid compounds in genitourinary disorders<\/strong><\/span><\/p>\n<p>Prof. Ani Gasparyan Hovhannisyan, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1Bc_O_NZ_WhHWFKR7V3FIubbBVhVSDjCm\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.12. Therapeutic potential of the use of cannabinoid compounds in the treatment of ophthalmologic pathologies<\/strong><\/span><\/p>\n<p>Prof. Francisco Navarrete Rueda, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1tgCdvxE00xa1Zc8krrEWq-UaoWGefqxc\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Lecture 4.13. Cannabinoids in dermatology<\/strong><\/span><\/p>\n<p>Prof. Mar\u00eda Salud Garc\u00eda Guti\u00e9rrez, Institute of Neurosciences, CSIC\/Universidad Miguel Hern\u00e1ndez, Spain<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1p0g_U0upzGiywzxtI9I7uVcgX9LYSmRI\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><span style=\"color: #333333\"><strong>Section 5. Patents and cannabinoid research seminar<\/strong><\/span><\/p>\n<p><span style=\"color: #0000ff\"><strong>Patent Seminar: Patents related to cannabinoid compounds\u00a0<\/strong><\/span><\/p>\n<p>Prof. Ram\u00f3n Soto, National Autonomous University of Mexico, Mexico<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/1bio0xd8I6V2-Zds1VNNOzUFbsoIhTIFJ\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.17.4&#8243; _module_preset=\u00bbdefault\u00bb hover_enabled=\u00bb0&#8243; locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p><span style=\"color: #0000ff\"><strong><\/strong><\/span><\/p>\n<p><strong style=\"color: #0000ff\">Research Seminar: Genetically modified mice in neuropsychopharmacology research<\/strong><\/p>\n<p>Prof. Jan Rodr\u00edguez Parkitna, Maj Institute of Pharmacology Polish Academy of Sciences, Poland<\/p>\n\n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe loading=\"lazy\" src=\"https:\/\/drive.google.com\/file\/d\/11RqPknYRsTWFPo20kiAwAU5bh8YlWnlV\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>0. Introduction Cannabis: therapeutic or recreational drug \n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe src=\"https:\/\/drive.google.com\/file\/d\/1UQOwp5aYne9TGExi06IZFovd2Nx0SH4S\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n Section 1. Botany, pharmacognosy, pharmacology and recreational use of the cannabis plant Lecture 1.1. History of cannabis, from its origins to today&#8217;s products Prof. Javier Muriel Serrano, Department of Pharmacology, Pediatrics and Organic Chemistry, Universidad Miguel Hern\u00e1ndez, Spain \n<!-- iframe plugin v.4.5 wordpress.org\/plugins\/iframe\/ -->\n<iframe src=\"https:\/\/drive.google.com\/file\/d\/1_wrRzb3lx1geBgax_kvuLJ87nMJkmqPK\/preview\" width=\"640\" height=\"480\" scrolling=\"yes\" class=\"iframe-class\" frameborder=\"0\"><\/iframe>\n Lecture 1.2. [&hellip;]<\/p>\n","protected":false},"author":3782,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<p>Temario del curso online sobre <strong>Nuevas competencias profesionales para el medico del siglo XXI:<\/strong><\/p><p><strong>1.<\/strong> La comunicaci\u00f3n no verbal<\/p><p><strong>2.<\/strong>\u00a0Comunicar con enfermos y familiares<\/p><p><strong>3.<\/strong>\u00a0Comunicar en situaciones especiales: con el enfermo agresivo, dar malas noticias, con el enfermo que no quiere dejar de serlo<\/p><p><strong>4.<\/strong>\u00a0Otras formas de comunicar: confrontar, dar feedback<\/p><p><strong>5.<\/strong>\u00a0O\u00edr, escuchar, preguntar y mediar<\/p><p><strong>6.<\/strong>\u00a0Ense\u00f1ar<\/p><p><strong>7.<\/strong>\u00a0Aprender<\/p><p><strong>8.<\/strong>\u00a0Investigar<\/p><p><strong>9.<\/strong>\u00a0Manejar la estad\u00edstica b\u00e1sica para investigar<\/p><p><strong>10.<\/strong>\u00a0El buen m\u00e9dico debe ser competente, un buen profesional<\/p><p><strong>11.<\/strong>\u00a0El buen m\u00e9dico debe ser muy humano<\/p><p><strong>12.<\/strong>\u00a0El buen m\u00e9dico debe ser rico en valores<\/p><p><strong>13.<\/strong>\u00a0El buen m\u00e9dico debe estar motivado. El mobbing y el burn out<\/p><p><strong>14.<\/strong>\u00a0El buen m\u00e9dico debe conocerse bien<\/p><p><strong>15.<\/strong>\u00a0El buen m\u00e9dico debe sustentar potentes componentes \u00e9ticos<\/p><p><strong>16.<\/strong>\u00a0El buen m\u00e9dico debe ver el envejecimiento de otra manera<\/p><p><strong>17.<\/strong>\u00a0El buen m\u00e9dico debe enfrentarse bien con el final de la vida<\/p><p><strong>18.<\/strong>\u00a0El buen m\u00e9dico debe saber trabajar en equipo<\/p><p><strong>19.<\/strong>\u00a0El buen m\u00e9dico debe implicarse en la toma de decisiones compartidas<\/p><p><strong>20.<\/strong>\u00a0El buen m\u00e9dico debe saber liderar<\/p><p><strong>21.<\/strong>\u00a0El buen m\u00e9dico debe alistarse en el optimismo inteligente<\/p><p><strong>22.<\/strong>\u00a0El buen m\u00e9dico debe ser pro activo y atreverse a cambiar<\/p><p><strong>23.<\/strong>\u00a0El buen m\u00e9dico debe hacer bien la gesti\u00f3n cl\u00ednica<\/p><p><strong>24.<\/strong>\u00a0El buen m\u00e9dico debe mantener una actitud y visi\u00f3n positiva<\/p><p><strong>25.<\/strong>\u00a0El buen m\u00e9dico debe ser feliz en su trabajo y en la vida<\/p><p><strong>26.<\/strong>\u00a0El buen m\u00e9dico debe ser experto en el campo de las adiciones<\/p><p><strong>27.<\/strong>\u00a0El buen m\u00e9dico debe conocer bien el da\u00f1o que pueden producir las adiciones socialmente aceptadas como el tabaco y el alcohol<\/p><p><strong>28.<\/strong>\u00a0El buen m\u00e9dico debe ser capaz de fijarse metas realistas<\/p><p><strong>29.<\/strong>\u00a0El buen m\u00e9dico debe ser capaz de superar el estr\u00e9s<\/p><p><strong>30.<\/strong>\u00a0El buen m\u00e9dico debe conocer bien lo que es la salud y la enfermedad<\/p><p><strong>31.<\/strong>\u00a0El buen m\u00e9dico debe ser capaz de educar a sus enfermos en lo que es llevar una vida sana<\/p><p><strong>32.<\/strong>\u00a0El buen m\u00e9dico debe ser capaz de hacer ver a sus enfermos que son ricos<\/p><p><strong>33.<\/strong>\u00a0Ejercicios pr\u00e1cticos de los temas<\/p><p><strong>34.<\/strong>\u00a0Otros complementos educativos, v\u00eddeos, etc.<\/p><p><strong>35.<\/strong>\u00a0Complementos formativos, lecturas,etc.<\/p><p>\u00a0<\/p><p>\u00a0<\/p>","_et_gb_content_width":"","ngg_post_thumbnail":0,"_links_to":"","_links_to_target":""},"_links":{"self":[{"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/pages\/3082"}],"collection":[{"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/users\/3782"}],"replies":[{"embeddable":true,"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/comments?post=3082"}],"version-history":[{"count":0,"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/pages\/3082\/revisions"}],"wp:attachment":[{"href":"https:\/\/specialistcannabinoids.umh.es\/es\/wp-json\/wp\/v2\/media?parent=3082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}